Suzuki H et al. |
Induction of transplantation tolerance in adult rats by vascularized spleen transplantation. |
1997 |
Transplantation |
pmid:9293881
|
Stevens RB et al. |
Randomized trial of single-dose versus divided-dose rabbit anti-thymocyte globulin induction in renal transplantation: an interim report. |
2008 |
Transplantation |
pmid:18497677
|
Arns W et al. |
Pharmacokinetics and Clinical Outcomes of Generic Tacrolimus (Hexal) Versus Branded Tacrolimus in De Novo Kidney Transplant Patients: A Multicenter, Randomized Trial. |
2017 |
Transplantation |
pmid:28658202
|
Yang CW et al. |
Pharmacological preconditioning with low-dose cyclosporine or FK506 reduces subsequent ischemia/reperfusion injury in rat kidney. |
2001 |
Transplantation |
pmid:11740384
|
Moxey-Mims MM |
Increased incidence of insulin-dependent diabetes mellitus in pediatric renal transplant patients receiving tacrolimus (FK506) |
1999 |
Transplantation |
pmid:10440413
|
Jordan ML et al. |
Results of pancreas transplantation after steroid withdrawal under tacrolimus immunosuppression. |
2000 |
Transplantation |
pmid:10670637
|
Hirose R et al. |
Experience with daclizumab in liver transplantation: renal transplant dosing without calcineurin inhibitors is insufficient to prevent acute rejection in liver transplantation. |
2000 |
Transplantation |
pmid:10670644
|
Han DH et al. |
Effect of sirolimus on calcineurin inhibitor-induced nephrotoxicity using renal expression of KLOTHO, an antiaging gene. |
2010 |
Transplantation |
pmid:20562737
|
McGhee B et al. |
Therapeutic use of an extemporaneously prepared oral suspension of tacrolimus in pediatric patients. |
1997 |
Transplantation |
pmid:9326429
|
Yoshimura N et al. |
The direct effect of FK506 and rapamycin on interleukin 1(beta) and immunoglobulin production in vitro. |
1994 |
Transplantation |
pmid:7517078
|
Budde K et al. |
Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant recipients receiving tacrolimus: clinical, pharmacokinetic, and pharmacodynamic outcomes. |
2007 |
Transplantation |
pmid:17318074
|
Firdaous I et al. |
Pediatric intravenous FK506--how much are we really infusing? |
1994 |
Transplantation |
pmid:7517079
|
Tuteja S et al. |
The effect of gut metabolism on tacrolimus bioavailability in renal transplant recipients. |
2001 |
Transplantation |
pmid:11397967
|
Stifft F et al. |
Lower variability in 24-hour exposure during once-daily compared to twice-daily tacrolimus formulation in kidney transplantation. |
2014 |
Transplantation |
pmid:24686426
|
Reichenspurner H et al. |
Optimization of the immunosuppressive protocol after lung transplantation. |
1999 |
Transplantation |
pmid:10428269
|
Pilmore HL et al. |
Tacrolimus for the treatment of gout in renal transplantation: two case reports and review of the literature. |
2001 |
Transplantation |
pmid:11726837
|
Sampaio MS et al. |
Association of immunosuppressive maintenance regimens with posttransplant lymphoproliferative disorder in kidney transplant recipients. |
2012 |
Transplantation |
pmid:22129761
|
Koenen HJ et al. |
Superior T-cell suppression by rapamycin and FK506 over rapamycin and cyclosporine A because of abrogated cytotoxic T-lymphocyte induction, impaired memory responses, and persistent apoptosis. |
2003 |
Transplantation |
pmid:12792519
|
Jain A et al. |
Pharmacokinetics of tacrolimus in living donor liver transplant and deceased donor liver transplant recipients. |
2008 |
Transplantation |
pmid:18347534
|
Ishizuka J et al. |
Effects of FK506 and cyclosporine on dynamic insulin secretion from isolated dog pancreatic islets. |
1993 |
Transplantation |
pmid:7506454
|
Murase N et al. |
FK506 suppression of heart and liver allograft rejection. II: The induction of graft acceptance in rats. |
1990 |
Transplantation |
pmid:1700504
|
Robertsen I et al. |
Use of generic tacrolimus in elderly renal transplant recipients: precaution is needed. |
2015 |
Transplantation |
pmid:25148382
|
Kaplan B et al. |
Low bioavailability of cyclosporine microemulsion and tacrolimus in a small bowel transplant recipient: possible relationship to intestinal P-glycoprotein activity. |
1999 |
Transplantation |
pmid:10075604
|
Gaber AO et al. |
Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial. |
2008 |
Transplantation |
pmid:19005398
|
Erden E et al. |
Plasma FK506 levels in patients with histopathologically documented renal allograft rejection. |
1994 |
Transplantation |
pmid:7519801
|
Morikawa K et al. |
The distinct effects of FK506 on the activation, proliferation, and differentiation of human B lymphocytes. |
1992 |
Transplantation |
pmid:1281561
|
McDevitt-Potter LM et al. |
A multicenter experience with generic tacrolimus conversion. |
2011 |
Transplantation |
pmid:21788920
|
Roth D et al. |
Primary immunosuppression with tacrolimus and mycophenolate mofetil for renal allograft recipients. |
1998 |
Transplantation |
pmid:9458023
|
Gill JS et al. |
Screening for de novo anti-human leukocyte antigen antibodies in nonsensitized kidney transplant recipients does not predict acute rejection. |
2010 |
Transplantation |
pmid:20098280
|
Zhao W et al. |
Pharmacokinetic interaction between tacrolimus and amlodipine in a renal transplant child. |
2012 |
Transplantation |
pmid:22450597
|
Pascual J et al. |
Alemtuzumab induction and antibody-mediated kidney rejection after simultaneous pancreas-kidney transplantation. |
2009 |
Transplantation |
pmid:19136902
|
Ciancio G et al. |
A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring. |
2005 |
Transplantation |
pmid:16123718
|
Berg UB et al. |
Renal function before and long after liver transplantation in children. |
2001 |
Transplantation |
pmid:11544422
|
Irish W et al. |
Three-year posttransplant graft survival in renal-transplant patients with graft function at 6 months receiving tacrolimus or cyclosporine microemulsion within a triple-drug regimen. |
2003 |
Transplantation |
pmid:14688516
|
Gruessner RW et al. |
Mycophenolate mofetil in pancreas transplantation. |
1998 |
Transplantation |
pmid:9721799
|
Emond JC et al. |
Improved results of living-related liver transplantation with routine application in a pediatric program. |
1993 |
Transplantation |
pmid:7682738
|
Chisholm MA et al. |
Coadministration of tacrolimus with anti-acid drugs. |
2003 |
Transplantation |
pmid:12973105
|
Kershner RP and Fitzsimmons WE |
Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation. |
1996 |
Transplantation |
pmid:8878385
|
Devlin J et al. |
Nitric oxide generation. A predictive parameter of acute allograft rejection. |
1994 |
Transplantation |
pmid:7522365
|
Jordan ML et al. |
Tacrolimus rescue therapy for renal allograft rejection--five-year experience. |
1997 |
Transplantation |
pmid:9020321
|
Higgins R et al. |
Rises and falls in donor-specific and third-party HLA antibody levels after antibody incompatible transplantation. |
2009 |
Transplantation |
pmid:19300192
|
Steiner RW |
Steroid withdrawal in kidney transplantation: the subgroup fallacy. |
2011 |
Transplantation |
pmid:21336084
|
Dhar DK et al. |
The salutary effect of FK506 in ischemia-reperfusion injury of the canine liver. |
1992 |
Transplantation |
pmid:1384188
|
Bashuda H et al. |
Induction of persistent allograft tolerance in the rat by combined treatment with anti-leukocyte function-associated antigen-1 and anti-intercellular adhesion molecule-1 monoclonal antibodies, donor-specific transfusion, and FK506. |
1996 |
Transplantation |
pmid:8693525
|
Hughes JR et al. |
Blood levels of TGFbeta1 in liver transplant recipients receiving either tacrolimus or micro-emulsified cyclosporine. |
1999 |
Transplantation |
pmid:10480422
|
Cacciarelli TV et al. |
Management of posttransplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy. |
1998 |
Transplantation |
pmid:9808490
|
Macphee IA et al. |
Tacrolimus pharmacogenetics: the CYP3A5*1 allele predicts low dose-normalized tacrolimus blood concentrations in whites and South Asians. |
2005 |
Transplantation |
pmid:15729180
|
Griffith BP et al. |
A prospective randomized trial of FK506 versus cyclosporine after human pulmonary transplantation. |
1994 |
Transplantation |
pmid:7512292
|
Sun S et al. |
Effect of tacrolimus on hemodynamics and absorption of experimental small intestinal transplants. |
1996 |
Transplantation |
pmid:8633368
|
Kashu Y et al. |
The effect of combination splenectomy and low-dose FK506 therapy on graft survival after liver allograft transplantation in rats. |
1996 |
Transplantation |
pmid:8633382
|